Biotechnology exchange traded funds (ETFs) are trading higher this morning as several large names in the sector prepare to announce their third-quarter earnings. Here are more stories on the subject that may interest you:
- 5 ETF Themes Investors Can Consider
- What Biotechnology ETFs Need to Thrive
- 7 Reasons Biotechnology ETFs Could Succeed
- Tom Lydon Talks Biotech, Corporate Bond ETFs on Fox Business
- Biotech Sector and ETFs Get a Lifeline
The opinions and forecasts expressed herein are solely those of Tom Lydon, and may not actually come to pass. Information on this site should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any product.